Economic Evaluation of Pharmaceuticals after Marketing Approval_Chinese Journal of Evidence-Based Medicine

Authors：

HU Shanlian

School of Public Health; Fudan University; Shanghai 200032; China;

Corresponding author：

Keywords：

Evidence-based drug evaluation; Post-marketing assessment; Pharmacoecomomic

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

This paper discusses the characteristics of pharmacoecomomics and its evaluation methods. After launching a drug to the market, a large amount of clinical use provides the opportunity to evaluate the effectiveness and adverse effects. The methods of economic evaluation in post-marketing pay more attention to the value-added pharmacoeconomics activities to maintain product status, such as risk-benefit analysis, drug reimbursement application and budget impact analysis, etc.

Citation： HU Shanlian. Economic Evaluation of Pharmaceuticals after Marketing Approval. Chinese Journal of Evidence-Based Medicine, 2005, 05(5): 353-356. doi: Copy

1.	李廷谦, 王刚, 王蕾. 循证医学与中药上市后的再评价[J]. 中国循证医学杂志, 2004; 4(4): 217～221.
2.	胡大一, 杨进刚. 应重视上市后药物安全性的循证医学再评价--罗非昔布召回的意义[J]. 中国循证医学杂志, 2005; 5(2): 94～96.
3.	Li TQ, Wang G, Wang L. Evidence-based medicine and reassessment of post-marketed Chinese herbs[J]. Chinese Journal of Evidence-based Medicine, 2004; 4(4): 217-221.
4.	Farley Dixie. Benefit vs. Risk: How FDA Approves New Drugs [EB/OL]. FDA Consumer Special Report. 1995 Jan. Available from: URL: http://www.fda.gov/fdac/special/new drug/benefits.html.
5.	Langley PC. Pharmacoeconomics in Drug Development and Marketing: An Overview. ISPOR Distance Learning Program. Monograph. 2004.
6.	Langley PC. Pharmacoeconomics in Market Entry and Market Support. ISPOR Distance Learning Program. Monograph. 2004.
7.	Hu DY, Yang JG. Evidence-Based safety reassessment of post-marketed drug-important of recall of Refecoxib[J]. Chinese Journal of Evidence-based Medicine, 2005; 5(2): 94-96.
8.	Barden J, Edwards JE, McQuay HJ, Moore RA. Single Dose Oral Celecoxib for Postopreative Pain (Cochrane Reviw). In: The Cochrane Library, Issue 1, 2005. Chichester, UK: John Wiley & Sons, Ltd.
9.	Barden J, Edwards J, Moore RA, McQuay HJ. Single Dose Oral Rofecoxib for Postoperative Pain (Cochrane Reviw). In: The Cochrane Library, Issue 1, 2005. Chichester, UK: John Wiley & Sons, Ltd.
10.	Jackson CM, Lipworth B. Benefit-risk assessment of long-acting beta2-agonists in asthma[J]. Drug Saf, 2004; 27(4): 243-270.

1. 李廷谦, 王刚, 王蕾. 循证医学与中药上市后的再评价[J]. 中国循证医学杂志, 2004; 4(4): 217～221.
2. 胡大一, 杨进刚. 应重视上市后药物安全性的循证医学再评价--罗非昔布召回的意义[J]. 中国循证医学杂志, 2005; 5(2): 94～96.
3. Li TQ, Wang G, Wang L. Evidence-based medicine and reassessment of post-marketed Chinese herbs[J]. Chinese Journal of Evidence-based Medicine, 2004; 4(4): 217-221.
4. Farley Dixie. Benefit vs. Risk: How FDA Approves New Drugs [EB/OL]. FDA Consumer Special Report. 1995 Jan. Available from: URL: http://www.fda.gov/fdac/special/new drug/benefits.html.
5. Langley PC. Pharmacoeconomics in Drug Development and Marketing: An Overview. ISPOR Distance Learning Program. Monograph. 2004.
6. Langley PC. Pharmacoeconomics in Market Entry and Market Support. ISPOR Distance Learning Program. Monograph. 2004.
7. Hu DY, Yang JG. Evidence-Based safety reassessment of post-marketed drug-important of recall of Refecoxib[J]. Chinese Journal of Evidence-based Medicine, 2005; 5(2): 94-96.
8. Barden J, Edwards JE, McQuay HJ, Moore RA. Single Dose Oral Celecoxib for Postopreative Pain (Cochrane Reviw). In: The Cochrane Library, Issue 1, 2005. Chichester, UK: John Wiley & Sons, Ltd.
9. Barden J, Edwards J, Moore RA, McQuay HJ. Single Dose Oral Rofecoxib for Postoperative Pain (Cochrane Reviw). In: The Cochrane Library, Issue 1, 2005. Chichester, UK: John Wiley & Sons, Ltd.
10. Jackson CM, Lipworth B. Benefit-risk assessment of long-acting beta2-agonists in asthma[J]. Drug Saf, 2004; 27(4): 243-270.

Chinese Journal of Evidence-Based Medicine

Economic Evaluation of Pharmaceuticals after Marketing Approval

Abstract Full text Figures/Tables Video References Cited by

Format

Content